The iconic rise of Viagra has long been a example of pharmaceutical success, yet its legacy within the broader market now presents questions about future gains. Alternative versions are diminishing market share, prompting concerns that betting on companies closely tied to Viagra's once-dominant standing could be a speculative move , especially give